U.S. Markets close in 40 mins
  • S&P 500

    3,451.34
    +15.78 (+0.46%)
     
  • Dow 30

    28,363.69
    +152.87 (+0.54%)
     
  • Nasdaq

    11,496.02
    +11.33 (+0.10%)
     
  • Russell 2000

    1,627.50
    +23.73 (+1.48%)
     
  • Crude Oil

    40.66
    +0.63 (+1.57%)
     
  • Gold

    1,905.80
    -23.70 (-1.23%)
     
  • Silver

    24.76
    -0.48 (-1.89%)
     
  • EUR/USD

    1.1823
    -0.0043 (-0.3665%)
     
  • 10-Yr Bond

    0.8480
    +0.0320 (+3.92%)
     
  • Vix

    27.96
    -0.69 (-2.41%)
     
  • GBP/USD

    1.3078
    -0.0065 (-0.4944%)
     
  • USD/JPY

    104.8920
    +0.3320 (+0.3175%)
     
  • BTC-USD

    13,078.42
    +2,021.41 (+18.28%)
     
  • CMC Crypto 200

    263.66
    +7.56 (+2.95%)
     
  • FTSE 100

    5,785.65
    +9.15 (+0.16%)
     
  • Nikkei 225

    23,474.27
    -92.73 (-0.39%)
     

UPDATED TIME: Alexion Fourth Quarter and Full Year 2019 Results Conference Call at 7:30am ET on Thursday, January 30, 2020

Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that it has updated the time of its fourth quarter and full year 2019 earnings call on January 30, 2020 to 7:30 a.m. Eastern Time. The call had previously been scheduled for 8:00 a.m. ET. All other aspects of the call remain unchanged.

The Company will report its financial results for the fourth quarter and full year ended December 31, 2019 before the US financial markets open on January 30, 2020.

To participate in the conference call, dial (866) 762-3111 (USA) or (210) 874-7712 (International), conference ID 3571658 shortly before 7:30 a.m. ET. The audio webcast can be accessed on the Investor page of http://ir.alexion.com and an archived version will be available for a limited time following the presentation.

[ALXN-G]

View source version on businesswire.com: https://www.businesswire.com/news/home/20200124005075/en/

Contacts

Investors
Susan Altschuller, Ph.D.
Vice President, Investor Relations
(857) 338-8788